Billionaire Bill Gates' Foundation Sold Its Microsoft Stake and Has 43% of Its $33 Billion Portfolio Invested in 2 Other Stocks

The Gates Foundation’s $33 billion equity portfolio remains concentrated in two value-oriented holdings: Berkshire Hathaway at about 25% of assets and WM at about 18%, while Microsoft exposure is being reduced as Gates donates shares over time. Microsoft trades at 25x forward earnings despite strong AI-driven cloud and software demand, while Berkshire trades at a 1.4x price-to-book ratio after solid Q1 results and WM’s EBITDA margin expanded 70 bps to 29.8%. The article is primarily portfolio commentary rather than a new company-specific catalyst.

Analysis

The positioning signal is less about the named holdings and more about the portfolio’s implicit mandate: monetize low-growth, cash-generative compounding while reducing single-name concentration risk. That creates a subtle headwind for the broad mega-cap growth complex because it reinforces a visible institutional preference for balance-sheet durability and buybacks over narrative-driven duration assets. In practice, that bias tends to show up first in flows: allocators chasing “quality value” can continue to bid up mature cash machines even when their absolute upside is limited.

For MSFT, the second-order effect is not fundamental deterioration but supply-overhang management. If a large insider/philanthropic seller is telegraphing multi-year distribution, the market can absorb it only if earnings revisions stay positive enough to offset it; otherwise valuation support becomes more fragile. The bigger risk is not the donation itself but the interaction with any AI capex pause or cloud re-acceleration miss, because at ~25x forward earnings the stock still needs sustained revision momentum to justify multiple stability.

BRK.B and WM look like classic “good, not great” compounding assets that can remain overowned in quality screens, but both have near-term upside ceilings if the market starts rewarding growth acceleration elsewhere. BRK.B’s catalyst is operational execution plus any signal that buybacks become more aggressive; absent that, the stock may simply be a capital-preservation parking spot. WM’s moat is real, but the premium valuation means incremental upside likely comes from margin expansion and tuck-in capital deployment rather than multiple expansion.

The contrarian miss is that this type of portfolio often lags in a risk-on leadership tape, yet can outperform sharply in a slowdown or volatility spike. Investors may be overestimating the permanence of the value tilt and underestimating how quickly the foundation could be forced to rebalance if Berkshire distributions remain elevated or MSFT ownership declines. That makes the setup more tactical than strategic over the next 3-12 months.

Key Decisions for Investors

• Long BRK.B vs short QQQ for 3-6 months: pair the cash-rich, lower-duration compounder against extended mega-cap tech exposure; target 8-12% relative outperformance if rates stay sticky or breadth narrows.
• Trim or hedge MSFT into strength over the next 1-2 quarters: use call spreads or overwrite upside if the stock re-rates above current multiples without a commensurate revision step-up; risk is capped if AI demand surprises again.
• Maintain a core long WM, but only on pullbacks into the high-20s forward earnings band: the business is defensible, yet the valuation limits upside; best expressed as a defensive carry position rather than a momentum trade.
• Add BRK.B on any drawdown tied to weak buyback optics: 12-month risk/reward favors accumulation when price-to-book compresses further, because the downside is cushioned by earnings power and cash hoard optionality.
• Avoid chasing the ‘quality value’ basket indiscriminately: prefer pair trades (BRK.B/WM long vs high-multiple software or unprofitable AI infrastructure shorts) where the thesis is multiple normalization rather than absolute market direction.